Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients

Objective Numerous ultrasound studies have suggested that a typical enlarged area of echogenicity in the substantia nigra (SN+) can help diagnose idiopathic Parkinson's disease (IPD). Almost all these studies were retrospective and involved patients with well-established diagnoses and long-disease duration. In this study the diagnostic accuracy of transcranial sonography (TCS) of the substantia nigra in the patient with an undiagnosed parkinsonian syndrome of recent onset has been evaluated. Design Prospective cohort study for diagnostic accuracy. Setting Neurology outpatient clinics of two teaching hospitals in the Netherlands. Patients 196 consecutive patients, who were referred to two neurology outpatient clinics for analysis of clinically unclear parkinsonism. Within 2 weeks of inclusion all patients also underwent a TCS and a 123I-ioflupane Single Photon Emission CT (FP-CIT SPECT) scan of the brain (n=176). Outcome measures After 2 years, patients were re-examined by two movement disorder specialist neurologists for a final clinical diagnosis, that served as a surrogate gold standard for our study. Results Temporal acoustic windows were insufficient in 45 of 241 patients (18.67%). The final clinical diagnosis was IPD in 102 (52.0%) patients. Twenty-four (12.3%) patients were diagnosed with atypical parkinsonisms (APS) of which 8 (4.0%) multisystem atrophy (MSA), 6 (3.1%) progressive supranuclear palsy (PSP), 6 (3.1%) Lewy body dementia and 4 (2%) corticobasal degeneration. Twenty-one (10.7%) patients had a diagnosis of vascular parkinsonism, 20 (10.2%) essential tremor, 7 (3.6%) drug-induced parkinsonism and 22 (11.2%) patients had no parkinsonism but an alternative diagnosis. The sensitivity of a SN+ for the diagnosis IPD was 0.40 (CI 0.30 to 0.50) and the specificity 0.61 (CI 0.52 to 0.70). Hereby the positive predictive value (PPV) was 0.53 and the negative predictive value (NPV) 0.48. The sensitivity and specificity of FP-CIT SPECT scans for diagnosing IPD was 0.88 (CI 0.1 to 0.95) and 0.68 (CI 0.58 to 0.76) with a PPV of 0.75 and an NPV of 0.84. Conclusions The diagnostic accuracy of TCS in early stage Parkinson's disease is not sufficient for routine clinical use. Clinicaltrials.gov identifier NCT0036819

[1]  D. Berg,et al.  Differentiation of Parkinson’s disease and atypical parkinsonian syndromes by transcranial ultrasound , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[2]  Uwe Walter,et al.  Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease. , 2007, Archives of neurology.

[3]  A. Kessels,et al.  Protocol of a prospective study on the diagnostic value of transcranial duplex scanning of the substantia nigra in patients with parkinsonian symptoms , 2007, BMC neurology.

[4]  Ahlskog,et al.  Diagnosis and differential diagnosis of Parkinson's disease and parkinsonism. , 2000, Parkinsonism & related disorders.

[5]  R. Munhoz,et al.  The differential diagnoses of parkinsonism: Findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics , 2010, Clinical Neurology and Neurosurgery.

[6]  Ping-Keung Yip,et al.  Transcranial color-coded sonography helps differentiation between idiopathic Parkinson's disease and vascular parkinsonism , 2007, Journal of Neurology.

[7]  B U Meyer,et al.  Brain parenchyma sonography discriminates Parkinson’s disease and atypical parkinsonian syndromes , 2002, Neurology.

[8]  Regina Katzenschlager,et al.  Olfaction and Parkinson's syndromes: its role in differential diagnosis , 2004, Current opinion in neurology.

[9]  K. Jellinger,et al.  Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. , 1998, Archives of neurology.

[10]  Daniela Berg,et al.  Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. , 2002, Archives of neurology.

[11]  R. Hilker,et al.  Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  P. Mir,et al.  Clinical features and 123I-FP-CIT SPECT imaging in drug-induced parkinsonism and Parkinson’s disease , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  Klaus Fassbender,et al.  Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease. , 2006, Brain : a journal of neurology.

[14]  G Becker,et al.  Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography , 1995, Neurology.

[15]  C. Adler,et al.  Sniffing out Parkinson Disease: Can Olfactory Testing Differentiate Parkinsonian Disorders? , 2007, The neurologist.

[16]  Niall Quinn,et al.  Accuracy of clinical diagnosis of progressive supranuclear palsy , 2004, Movement disorders : official journal of the Movement Disorder Society.

[17]  L. Hakamies,et al.  [Corticobasal degeneration]. , 2001, Duodecim; laaketieteellinen aikakauskirja.

[18]  D. Dressler,et al.  Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[19]  W. Mess,et al.  Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes. , 2010, International review of neurobiology.

[20]  J. Jeng,et al.  Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[21]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[22]  Paola Piccini,et al.  Functional brain imaging in the differential diagnosis of Parkinson's disease , 2004, The Lancet Neurology.

[23]  Arūnas Lukoševičius,et al.  Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromes , 2012, BMC Neurology.

[24]  Jan Booij,et al.  Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3‐year European multicenter study with repeat [123I]FP‐CIT SPECT , 2009, Movement disorders : official journal of the Movement Disorder Society.

[25]  C. Counsell,et al.  Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[26]  Joseph Classen,et al.  Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[27]  Daniela Berg,et al.  Five‐year follow‐up study of hyperechogenicity of the substantia nigra in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[28]  W. Mess,et al.  The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans , 2008, BMC neurology.

[29]  Petr Hlustík,et al.  Hyperechogenicity of the Substantia Nigra in Parkinson's Disease , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[30]  G Becker,et al.  Vulnerability of the nigrostriatal system as detected by transcranial ultrasound , 1999, Neurology.

[31]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[32]  R. Hilker,et al.  Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[33]  D. Brooks Imaging Approaches to Parkinson Disease , 2010, Journal of Nuclear Medicine.

[34]  N P Quinn,et al.  What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? , 2000, Journal of neurology, neurosurgery, and psychiatry.

[35]  V. Demarin,et al.  Distinguishing Parkinson’s disease and essential tremor with transcranial sonography , 2009, Acta neurologica Scandinavica.

[36]  R. Benecke,et al.  Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease , 2002, Journal of Neural Transmission.

[37]  A. Kessels,et al.  Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes , 2007, BMC neurology.

[38]  H. Miwa,et al.  Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations. , 2007, Internal medicine.

[39]  J. P. Brandel,et al.  Accuracy of the Clinical Diagnosis of Corticobasal Degeneration , 1997, Neurology.

[40]  R. Hustinx,et al.  The reliability of transcranial duplex scanning in parkinsonian patients: comparison of different observers and ultrasound systems. , 2010, Ultraschall in der Medizin.

[41]  G. Seidel,et al.  Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles , 2007, Journal of Neurology.

[42]  Lucas M Bachmann,et al.  Multivariable adjustments counteract spectrum and test review bias in accuracy studies. , 2009, Journal of clinical epidemiology.

[43]  Michal Bar,et al.  Transcranial sonography in movement disorders. , 2008, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[44]  Matthias Reimold,et al.  The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study , 2008, The Lancet Neurology.

[45]  Werner Poewe,et al.  Midbrain sonography in patients with essential tremor , 2007, Movement disorders : official journal of the Movement Disorder Society.

[46]  J. Patterson,et al.  Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland , 2009, Movement disorders : official journal of the Movement Disorder Society.

[47]  C. Trenkwalder,et al.  Substantia nigra echogenicity in progressive supranuclear palsy , 2010, Movement disorders : official journal of the Movement Disorder Society.

[48]  D. Dressler,et al.  Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia , 2006, Journal of Neurology.

[49]  Uwe Walter,et al.  Transcranial sonography findings related to non-motor features of Parkinson's disease , 2010, Journal of the Neurological Sciences.

[50]  M. Onofrj,et al.  Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium , 2006, Neurology.

[51]  W. Lee,et al.  Midbrain transcranial sonography in Korean patients with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[52]  A. Lang,et al.  The many faces of corticobasal degeneration. , 2007, Parkinsonism & related disorders.

[53]  D. Dressler,et al.  Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy , 2004, Neurology.

[54]  D R Rajput,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[55]  D. Berg,et al.  Predictive value of transcranial sonography in the diagnosis of Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[56]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[57]  F. Cardoso,et al.  Etiology of parkinsonism in a Brazilian movement disorders clinic. , 1998, Arquivos de neuro-psiquiatria.

[58]  The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations , 2003, Movement disorders : official journal of the Movement Disorder Society.

[59]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[60]  Florian Doepp,et al.  Brain parenchyma sonography and 123I‐FP‐CIT SPECT in Parkinson's disease and essential tremor , 2008, Movement disorders : official journal of the Movement Disorder Society.

[61]  Daniela Berg,et al.  Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings , 2001, Journal of Neurology.

[62]  H. Benamer,et al.  Differentiating vascular parkinsonism from idiopathic Parkinson's disease: A systematic review , 2010, Movement disorders : official journal of the Movement Disorder Society.

[63]  M. Kaps,et al.  Transcranial sonography for diagnosis of Parkinson's disease , 2010, BMC neurology.